7.4 Medicare Prescription Payment Plan (Drug-Cost Smoothing)

AHIP Medicare Certification Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction

1.1 About the AHIP Medicare Certification Exam 1.2 How to Use This Study Guide

2 Chapter 2: Medicare Program Fundamentals

2.1 What Medicare Is: Program Structure & How Parts A–D Fit Together 2.2 Medicare Part A — Hospital Insurance 2.3 Medicare Part B — Medical Insurance 2.4 Medicare Eligibility Rules (Age 65, Disability, ESRD, ALS)

3 Chapter 3: Medicare Enrollment Periods

3.1 Initial Enrollment Period (IEP) 3.2 Annual Enrollment Period (AEP): October 15 – December 7 3.3 Medicare Advantage Open Enrollment Period (MA OEP): January 1 – March 31 3.4 Special Enrollment Periods (SEPs) & Qualifying Life Events 3.5 Late Enrollment Penalties (Part A, Part B, Part D)

4 Chapter 4: Medigap & Coordination of Coverage

4.1 Medigap (Medicare Supplement) Basics & Guaranteed Issue Rights 4.2 Dual Eligibility & Medicare Savings Programs 4.3 How Original Medicare, MA, Part D & Medigap Interact

5 Chapter 5: Medicare Advantage Plan Types

5.1 Medicare Advantage (Part C) Overview: How MA Differs from Original Medicare 5.2 HMO & HMO-POS Plans 5.3 PPO Plans 5.4 PFFS Plans (Private Fee-for-Service) 5.5 MSA Plans (Medicare Medical Savings Accounts) 5.6 Cost Plans & Employer Group Waiver Plans (EGWPs)

6 Chapter 6: Special Needs Plans & MA Plan Design

6.1 Special Needs Plans (SNPs) Overview 6.2 D-SNP — Dual-Eligible Special Needs Plans 6.3 C-SNP & I-SNP — Chronic Condition & Institutional Special Needs Plans 6.4 MA Benefits, MOOP & Supplemental Benefits 6.5 MA Star Ratings & Plan Quality

7 Chapter 7: Part D Structure & the 2026 Redesign

7.1 Part D Overview & Eligibility 7.2 Formularies & Drug Tiers 7.3 The 2026 Part D Benefit Redesign ($2,100 OOP Cap, $615 Max Deductible, Catastrophic Phase) 7.4 Medicare Prescription Payment Plan (Drug-Cost Smoothing)

8 Chapter 8: Part D Costs, Assistance & Appeals

8.1 Low-Income Subsidy (LIS) / Extra Help 8.2 Part D Late Enrollment Penalty & Creditable Coverage 8.3 Coverage Determinations, Exceptions & Appeals

9 Chapter 9: CMS Marketing Rules & Scope of Appointment

9.1 CMS Medicare Communications & Marketing Guidelines (MCMG) Overview 9.2 Scope of Appointment (SOA): the 48-Hour Rule & Exceptions 9.3 Permitted vs. Prohibited Marketing & Sales Activities 9.4 Marketing Events vs. Educational Events

10 Chapter 10: Enrollment & Disclosure Requirements

10.1 The Pre-Enrollment Checklist (PEC) 10.2 Enrollment Procedures & Application Requirements 10.3 Call Recording & Third-Party Marketing Organization (TPMO) Disclaimers 10.4 Agent & Broker Compensation Rules

11 Chapter 11: Marketing Conduct & Oversight

11.1 Cross-Selling Restrictions & Nominal Gift Value Rules 11.2 Marketing to Vulnerable Populations & Non-Discrimination in Sales 11.3 Website, Social Media & Advertising Compliance 11.4 Complaint Tracking Module (CTM) & Agent Oversight

12 Chapter 12: Understanding Fraud, Waste & Abuse

12.1 Defining Fraud, Waste & Abuse (and the Difference Between Them) 12.2 The False Claims Act 12.3 The Anti-Kickback Statute

13 Chapter 13: Compliance Laws & Screening

13.1 The Stark Law (Physician Self-Referral) 13.2 HIPAA Privacy & Security Basics 13.3 The OIG Exclusion List & Sanctioned-Provider Screening

14 Chapter 14: Reporting, Compliance Programs & Consequences

14.1 Detecting & Reporting FWA 14.2 Compliance Program Requirements (Seven Core Elements) & Non-Discrimination Training 14.3 Consequences & Corrective Action Plans

7.4 Medicare Prescription Payment Plan (Drug-Cost Smoothing)

Key Takeaways Explain This Topic AI

The Medicare Prescription Payment Plan (M3P) is a voluntary, free option — not insurance and not a discount — that lets Part D enrollees pay $0 at the pharmacy and instead receive smoothed monthly bills from their plan.

The total amount a beneficiary owes does not change under M3P; only the timing of payment changes, using the formula (Remaining Balance + New OOP Costs) ÷ Months Remaining.

The earlier in the year a beneficiary opts in, the lower each monthly payment — opting in during January can mean roughly $175/month versus roughly $1,050/month for a November opt-in on the same $2,100 obligation.

M3P does not cover monthly premiums, does not reduce the annual out-of-pocket cap, and non-payment leads to removal from the program (with a grace period) but not loss of Part D coverage.

Since 2025, CMS requires all Part D sponsors to notify enrollees annually about M3P, making it a tested Module 4 marketing-compliance topic as well as a Module 3 product-mechanics topic.

Last updated: July 2026

Why the Medicare Prescription Payment Plan Matters on the AHIP Exam

The Medicare Prescription Payment Plan (M3P) , sometimes called "drug-cost smoothing," is the newest major feature in Part D — it launched January 1, 2025 and is fully operational for plan year 2026. Because it is new, CMS has made it a mandatory disclosure item for every Part D sponsor, which pulls it directly into Module 4 (Marketing & Sales Compliance) as well as Module 3. AHIP exam-writers favor testing brand-new CMS requirements in the year or two after launch, precisely because agents are most likely to have outdated or incomplete knowledge — expect at least one M3P question.

What M3P Actually Is

M3P is not insurance, and it is not a discount. It is strictly a cash-flow tool : it lets a Part D enrollee (in either a standalone PDP or an MA-PD) elect to pay $0 at the pharmacy counter for covered prescriptions and instead receive a monthly bill from their plan that spreads their out-of-pocket drug costs evenly across the remaining months of the calendar year. The total dollar amount the beneficiary owes does not change — M3P only changes when they pay it, not how much . This distinction is the single most-tested concept in this section.

Who Can Use It

Any Part D enrollee is eligible to opt in — there is no income or medical requirement . However, it is most valuable for beneficiaries who expect a large drug cost early in the year (for example, someone facing a $2,100 specialty drug bill in January who would otherwise have to pay that full amount at the pharmacy in one shot, rather than smoothing it across the months ahead).

How Enrollment Works

Participation is voluntary and free — there is no fee to opt in.

Beneficiaries opt in through their plan , not through Medicare.gov directly — by phone or through the plan's website.

Beneficiaries can opt in during the Annual Enrollment Period (AEP, October 15 – December 7) or at any point during the plan year , but only prospectively — M3P cannot retroactively reimburse a beneficiary for costs they already paid at the pharmacy before opting in.

Standard elections must be processed before the next fill ; urgent elections (submitted close to a pharmacy pickup) must be processed within 24 hours so the beneficiary is not stuck paying full price while waiting on paperwork.

The Monthly Cap Formula

All Part D plans must use the same CMS-mandated formula to calculate a participant's monthly bill:

Monthly Payment = (Remaining Balance + New Out-of-Pocket Costs Incurred) ÷ Months Remaining in the Plan Year

Because the formula divides by the number of months left in the year, the earlier a beneficiary opts in, the smaller each monthly payment becomes — this is the single most important planning point for agents to communicate.

• Opt-In Month Total Obligation Months Remaining Approx. Monthly Payment
• January $2,100 12 ~$175/month
• July $2,100 6 ~$350/month
• November $2,100 2 ~$1,050/month

An agent who waits to mention M3P until AEP in October or November is doing their client a disservice if that client is likely to hit a high drug cost early the following year — the earlier the opt-in, the smoother (and smaller) each installment.

Compliance and Marketing Requirements

Since 2025, CMS requires every Part D plan sponsor to send an annual notice to all enrollees describing the M3P option, and to make information about it available at the point of enrollment and at the pharmacy counter when a beneficiary's out-of-pocket cost for a single fill would exceed a CMS-set threshold. Agents and brokers must be able to explain M3P accurately as part of their marketing and enrollment conduct obligations — this is the reason M3P knowledge is tested alongside Module 4's marketing compliance rules, not treated purely as a Module 3 product detail.

Important Limits and Traps

M3P applies only to covered Part D drug costs — it does not cover or smooth monthly premiums , which are still billed separately and on their own schedule.

M3P does not reduce a beneficiary's total annual out-of-pocket obligation — the 2026 $2,100 cap still applies in full; M3P only changes the payment cadence.

If a beneficiary fails to pay their monthly M3P bill, the plan must provide a grace period before removing them from the program; non-payment can lead to removal from M3P but does not cause loss of Part D coverage itself.

If a participant switches plans mid-year (for example, during a valid SEP), any remaining M3P balance transfers to the new plan rather than being forgiven or restarted.

Exam Scenario

A client is diagnosed in February with a condition requiring a $2,100 specialty drug fill that same month. If she pays out of pocket immediately, she owes the full $2,100 at the pharmacy. If she opts into M3P before that fill, she instead owes $0 at the pharmacy and is billed roughly $2,100 ÷ 11 months remaining (March through December, since the fill occurred in February) — a materially smaller monthly hit, spread over the balance of the plan year, with the same total amount owed either way.